Notification of officers at CDTL Mumbai as Government Analyst under section 20(2) of the Drugs and Cosmetics Act, 1940

## Policy Analysis Report: Amendment to Notification S.O. 2808(E) Regarding the Drugs and Cosmetics Act, 1940 **1. Executive Summary:** This report analyzes an amendment to the Government of India's notification S.O. 2808(E), dated 30th November, 2012, concerning the Drugs and Cosmetics Act, 1940. The amendment, issued on June 22, 2021, through notification S.O. 2449(E), adds nineteen individuals to a list of personnel, all identified as Junior Scientific Assistants. This report focuses on the specific changes introduced by this amendment and their potential impact, acknowledging the limited information available within the provided text. **2. Introduction:** The purpose of this report is to provide an informative overview of the amendment to notification S.O. 2808(E), based solely on the provided government policy text. It outlines the amendment's objectives, key changes, affected parties, and potential impacts. **3. Policy Overview:** * **Original Policy:** This amendment pertains to the Government of India's notification S.O. 2808(E), dated 30th November, 2012, published in the Gazette of India, Extraordinary, Part II, Section 3, Subsection ii. The original notification concerns the Drugs and Cosmetics Act, 1940. * **Core Objective(s):** Based on the text, the core objective of the *amendment* is to add specific individuals to a list. The broader objective of the original notification is not explicitly stated in the provided text but can be inferred to relate to the regulation of drugs and cosmetics under the Drugs and Cosmetics Act, 1940. **4. Background and Rationale:** The amendment appears to be adding personnel to an existing list of individuals authorized to act under the scope of the original notification. The rationale for this specific amendment is likely to expand the operational capacity or expertise related to the Drugs and Cosmetics Act, 1940, by including these newly appointed Junior Scientific Assistants. The provided text does not offer further details on the specific circumstances necessitating this expansion. **5. Key Provisions / Changes:** This amendment specifically adds the following nineteen individuals, all identified as Junior Scientific Assistants, to the list referenced in the original notification S.O. 2808(E): * vi Smt. Swati S. Parikh, Junior Scientific Assistant; * vii Dr. Anantharama G Nayaka, Junior Scientific Assistant; * viii Shri Arun K. Nagarkar, Junior Scientific Assistant; * ix Shri Shrawan Kumar Singh, Junior Scientific Assistant; * x Smt. Aditi Vinod Bandre, Junior Scientific Assistant; * xi Smt. Smita George Chittilappilly, Junior Scientific Assistant; * xii Smt. Anindita S. Nandi, Junior Scientific Assistant; * xiii Smt. Harshada H. Talapadatur, Junior Scientific Assistant; * xiv Smt. Priyanka Rajendra Kori, Junior Scientific Assistant; * xv Shri Ashish W. Yenkar, Junior Scientific Assistant; * xvi Shri Amol Akash, Junior Scientific Assistant; * xvii Shri Ashok Kumar, Junior Scientific Assistant; * xviii Shri Jagdish S. Chaudhari, Junior Scientific Assistant; * xix Shri Hemant P. Magar, Junior Scientific Assistant. The specific part of the original policy being amended is the list of individuals authorized to act under the Drugs and Cosmetics Act, 1940 (as relevant to S.O. 2808(E)). The *new* provision is the inclusion of the listed Junior Scientific Assistants. The *effect* of this change is to potentially increase the capacity and/or scope of activities related to the implementation of the Drugs and Cosmetics Act, 1940. **6. Target Audience and Stakeholders:** The direct target audience and stakeholders for *this specific amendment* are the newly appointed Junior Scientific Assistants themselves and the agencies or departments they will be working within. Indirectly, any organization that operates in the Industry related to Drugs and Cosmetics and that are impacted by The Drugs and Cosmetics Act, 1940. **7. Implementation Aspects (Inferred):** * **Responsible agency/bodies mentioned:** The Ministry of Health and Family Welfare, Department of Health and Family Welfare, is the responsible body for issuing the notification. * **Timelines or procedures specified:** No specific timelines or procedures are outlined in the amendment text. * **Implementation Aspects Specific to the Changes:** The amendment primarily involves updating the existing list of personnel. Implementation would likely involve informing the relevant departments and stakeholders about the inclusion of these individuals and clarifying their roles and responsibilities within the existing framework of the Drugs and Cosmetics Act, 1940. **8. Expected Outcomes / Impact of Changes:** The likely intended outcome *of these specific changes* is to augment the existing workforce responsible for implementing and enforcing the Drugs and Cosmetics Act, 1940. This may lead to more efficient regulatory processes, increased testing and analysis capabilities, or broader coverage of relevant industries. The impact of the amendment will likely be felt through enhanced operational efficiency and potentially improved compliance with the Drugs and Cosmetics Act, 1940. **9. Conclusion:** The amendment to notification S.O. 2808(E), issued on June 22, 2021, adds nineteen Junior Scientific Assistants to an existing list of personnel related to the Drugs and Cosmetics Act, 1940. This amendment likely aims to enhance the capacity and effectiveness of regulatory activities related to drugs and cosmetics. The implications for stakeholders include potential improvements in regulatory efficiency and compliance.

Key Entities Referenced